Wikia

Psychology Wiki

Thyrotropin-releasing hormone

Talk0
34,142pages on
this wiki
Revision as of 20:13, March 24, 2008 by Dr Joe Kiff (Talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Assessment | Biopsychology | Comparative | Cognitive | Developmental | Language | Individual differences | Personality | Philosophy | Social |
Methods | Statistics | Clinical | Educational | Industrial | Professional items | World psychology |

Biological: Behavioural genetics · Evolutionary psychology · Neuroanatomy · Neurochemistry · Neuroendocrinology · Neuroscience · Psychoneuroimmunology · Physiological Psychology · Psychopharmacology (Index, Outline)


thyrotropin-releasing hormone
Symbol(s): TRH
Locus: 3 q13.3 -q21
EC number [1]
EntrezGene 7200
OMIM 275120
RefSeq NM_007117
UniProt P20396


Thyrotropin-releasing hormone (TRH), also called thyrotropin-releasing factor (TRF), thyroliberin or protirelin, is a tripeptide hormone that stimulates the release of thyroid-stimulating hormone and prolactin by the anterior pituitary.

ProductionEdit

TRH is produced by the hypothalamus, near the paraventricular nucleus.[1]

It travels across the median eminence to the pituitary via the hypophyseal portal system. It is released from cells called thyrotropes.[2]

In addition to the brain, TRH can also be detected in other areas of the body including the gastrointestinal system and pancreatic islets.

HistoryEdit

The sequence of TRH was first determined and the hormone synthesized by Roger Guillemin and Andrew V. Schally in 1969.[3][4]

Chemical propertiesEdit

Its molecular weight is 359.5 Da.

Its structure is:

(pyro)Glu-His-Pro-NH2

Clinical significanceEdit

It is used in pharmacology (brand name Relefact TRH®) to test the response of the anterior pituitary gland.

Medical preparations of TRH are used in diagnostic tests of thyroid disorders and in acromegaly.


A TRH test may be indicated if secondary hypothyroidism is suspected. Some patients may have low levels of circulating thyroid hormones and secondary hypothyroidism as a result of damage to the hypothalamic or pituitary control mechanisms that regulate thyroid function. The hypothalamus makes a small hormone called TRH that directs the synthesis and secretion of TSH from the pituitary gland. If these normal regulatory mechanisms are interrupted, the pituitary may not be able to produce appropriate levels of TSH and levels of thyroid hormones may decline, although the TSH remains appropriately normal. The TRH test involves administration of a small amount of TRH intravenously, following which levels of TSH will be measured at several subsequent time points using samples of blood taken from a peripheral vein. Patients with normal function of the hypothalamic-pituitary axis (HPA) respond by increasing the levels of TSH following TRH injection. Patients with compromised HPA function may exhibit a delayed, blunted, or absent response to TRH administration.TRH may cause nausea, vomiting and some patients experience an urge to urinate. Rarely, TRH may cause blood vessel constriction leading to hemorrhage in patients with pre-existing pituitary tumors. Accordingly, patients should be advised about the risks, albeit rare, of TRH testing.[www.mythyroid.com/TRHtest]

See alsoEdit

ReferencesEdit


External linksEdit

[2] [3]


|}

Target-derived NGF, BDNF, NT-3

|}



This page uses Creative Commons Licensed content from Wikipedia (view authors).

Around Wikia's network

Random Wiki